![]() |
Volumn 336, Issue 6083, 2012, Pages 911-915
|
Cost-benefit tradeoffs in engineered lac operons
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BACTERIAL PROTEIN;
BETA GALACTOSIDASE;
LACTOSE PERMEASE;
PROTEIN LACY;
UNCLASSIFIED DRUG;
CELL ORGANELLE;
COLIFORM BACTERIUM;
COST-BENEFIT ANALYSIS;
DEVELOPMENTAL BIOLOGY;
FITNESS;
GENE EXPRESSION;
MEASUREMENT METHOD;
PROTEIN;
QUANTITATIVE ANALYSIS;
TRADE-OFF;
ARTICLE;
BACTERIAL STRAIN;
BIOENGINEERING;
CELL FUNCTION;
COST BENEFIT ANALYSIS;
ENZYME ACTIVITY;
ESCHERICHIA COLI;
LACTOSE OPERON;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN SYNTHESIS;
QUANTITATIVE ANALYSIS;
REGULATORY MECHANISM;
BACTERIA (MICROORGANISMS);
ESCHERICHIA COLI;
|
EID: 84861204284
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.1219083 Document Type: Article |
Times cited : (84)
|
References (23)
|